Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prion proteins meet protein quality control.

Derek E Dimcheff1, John L Portis, Byron Caughey

  • 1Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases/NIH, Hamilton, MT 59840, USA. ddimcheff@nih.gov

Trends in Cell Biology
|July 3, 2003
PubMed
Summary

Protein quality control is crucial in transmissible spongiform encephalopathies (TSEs). Impaired proteasome function leads to toxic prion protein buildup, contributing to neurodegeneration.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multisite study: Predicting Lewy body disease using skin biopsy α-synuclein seed amplification assays.

Journal of neuropathology and experimental neurology·2026
Same author

Brain-Only Versus GI-Only Synucleinopathy: A Comprehensive Autopsy Study With Both IHC and SAA.

medRxiv : the preprint server for health sciences·2026
Same author

Differential patterns of central synucleinopathy and catecholaminergic abnormalities in Lewy body diseases and multiple system atrophy.

Parkinsonism & related disorders·2026
Same author

Correction to "Design of Tau Aggregation Inhibitors Using Iterative Machine Learning and a Polymorph-Specific Brain-Seeded Fibril Amplification Assay".

Journal of the American Chemical Society·2026
Same author

Classification of tauopathies from human brain homogenates through salt-modulated tau amplification.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

D178N prion protein mutation endows RML prions with new strain properties that do not mimic human genetic prion diseases.

Acta neuropathologica·2026

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Prion Disease Research

Background:

  • Transmissible spongiform encephalopathies (TSEs) are linked to protein misfolding and aggregation.
  • Protein quality-control systems, including the proteasome, are vital for cellular health.
  • Compromised proteasome function may lead to the accumulation of toxic proteins.

Purpose of the Study:

  • To explore the role of protein quality-control mechanisms in prion protein aggregation.
  • To investigate the link between proteasome function and the neurotoxicity of aggregated prion protein.
  • To contextualize these findings within broader research on proteasome inhibition and neurodegeneration.

Main Methods:

  • Review of recent scientific literature on TSEs and protein quality control.

Related Experiment Videos

  • Analysis of studies investigating prion protein aggregation and cellular localization.
  • Examination of research linking proteasome activity to neurodegenerative processes.

    • Main Results:

    • Evidence suggests protein quality-control pathways are involved in prion protein (PrP) aggregation.
    • Cytosolic accumulation of PrP is associated with neurotoxicity.
    • This accumulation appears to occur when proteasome function is impaired, overwhelming cellular quality control.

    Conclusions:

    • Protein quality-control mechanisms play a significant role in the pathogenesis of TSEs.
    • Proteasome dysfunction is a potential driver of neurotoxic prion protein accumulation.
    • These insights align with broader findings implicating proteasome inhibition in various neurodegenerative diseases.